We investigated whether injections of activated cytokine-induced killer ( CIK ) cells ( CD3 + / CD56 + and CD3 + / CD56 - T cells and CD3 - / CD56 + natural killer cells ) prolongs recurrence-free survival of patients after curative therapy for HCC .